Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (DE:JNJ)
XETRA:JNJ
Holding DE:JNJ?
Track your performance easily
JNJ Stock Chart & Stats
Day’s Range― - ―
52-Week Range€132.78 - €154.00
Previous CloseN/A
Volume223.00
Average Volume (3M)4.30K
Market Cap
$336.54B
Enterprise Value€407.32B
Total Cash (Recent Filing)$41.91B
Total Debt (Recent Filing)$22.44B
Price to Earnings (P/E)26.1
Beta0.08
Next Earnings
Jan 22, 2025EPS Estimate
2.52Next Dividend Ex-Date
Feb 18, 2025Dividend Yield3.34%
Share Statistics
EPS (TTM)5.37
Shares Outstanding2,407,623,000
10 Day Avg. Volume5,423
30 Day Avg. Volume4,300
Standard Deviation0.05
R-Squared0.06
Alpha0.00446
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.03
Price to Cash Flow (P/CF)11.10
P/FCF Ratio12.40
Enterprise Value/Market Cap1.21
Enterprise Value/Revenue5.10
Enterprise Value/Gross Profit6.95
Enterprise Value/Ebitda16.60
Forecast
1Y Price Target
€160.46Price Target Upside9.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Johnson & Johnson News
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyThe planned acquisition of ITCI should add an important growth driver in Caplyta.
Financial PerformanceThe current P/E of 13.7x forward 12-month EPS of $10.60 is at historical lows.
Product PipelineJNJ has a deep lineup of product launches and regulatory catalysts scheduled for 2025.
Bears Say
Acquisition And Debt ImpactITCI EPS dilution is worse than expected, with a significant impact due to financing costs.
Financial PerformanceNew 2025 FY guidance shows revenues below consensus, mostly due to foreign exchange impacts.
Product And Market ChallengesUS knees and hips performance was soft, with competitive pressures accelerating in the electrophysiology sector.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.04% Insiders
18.42% Mutual Funds
0.66% Other Institutional Investors
60.44% Public Companies and Individual Investors
JNJ FAQ
What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was €132.78 and its highest was €154.00 in the past 12 months.
What is Johnson & Johnson’s market cap?
Johnson & Johnson’s market cap is $336.54B.
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Jan 22, 2025 which is 9 days ago.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Jan 22, 2025. The company reported €1.958 earnings per share for the quarter, beating the consensus estimate of €1.912 by €0.046.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of €4.675 which represents an annual dividend yield of 3.34%. See more information on Johnson & Johnson dividends here
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate is 2.52.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,407,623,000 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of €1.958 in its last earnings report, beating expectations of €1.912. Following the earnings report the stock price went down -3.141%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Among the largest hedge funds holding Johnson & Johnson’s share is Fisher Asset Management LLC. It holds Johnson & Johnson’s shares valued at 1B.
---
Johnson & Johnson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€160.46 (9.63% Upside)
€160.46 (9.63% Upside)
Blogger Sentiment
Bullish
DE:JNJ Sentiment 92%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $147.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 83%
Bearish news 17%
Bearish news 17%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.71%
12-Months-Change
Fundamentals
Return on Equity
20.89%
Trailing 12-Months
Asset Growth
7.36%
Trailing 12-Months
Company Description
Johnson & Johnson
Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
---
JNJ Company Deck
---
JNJ Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Johnson & Johnson showed robust growth in sales and innovation in 2024, particularly in the Innovative Medicine and MedTech sectors. However, earnings were negatively impacted by STELARA biosimilars and recent acquisitions, while challenges in China and decreased margins were noted.Read More>---
JNJ Sales Breakdown
64.30% Innovative Medicine
35.70% MedTech
---
JNJ Stock 12 Month Forecast
Average Price Target
€160.46
▲(9.63% Upside)
Technical Analysis
Best Analysts Covering JNJ
1 Year
1 Year Success Rate
23/23 ratings generated profit
1 Year Average Return
+9.40%
reiterated a buy rating 8 months ago
Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.40% per trade.
---